Lynsay MacLaren

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Natalie N. Kinloch, Yanqin Ren, Winiffer D. Conce Alberto et al. · Nature Communications · 2021 · 100 citations · Full text

Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies

Jonathan Z. Li, Evgenia Aga, Ronald J. Bosch et al. · Clinical Infectious Diseases · 2021 · 83 citations · Full text

Innovations in Human Immunodeficiency Virus (HIV) Care Delivery During the Coronavirus Disease 2019 (COVID-19) Pandemic: Policies to Strengthen the Ending the Epidemic Initiative—A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Wendy S. Armstrong, Allison L. Agwu, Ernie-Paul Barrette et al. · Clinical Infectious Diseases · 2020 · 59 citations · Full text

Differential Levels of mRNAs for Cytokines, the Interleukin-2 Receptor and Class II DR/DQ Genes in Ovine Interstitial Pneumonia Induced by Maedi Visna Virus Infection

Chris Woodall, Lynsay MacLaren, N.J. Watt · Veterinary Pathology · 1997 · 37 citations

Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8⁺T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal

Talia M. Mota, Chase D. McCann, Ali Danesh et al. · Journal of Virology · 2020 · 24 citations · Full text